Bal Research Foundation - Due diligence report

A 360° intelligence report on Bal Research Foundation: trust score, financial health, credit view, compliance, directors, growth and distres…

2014-10-29 Bangalore, Karnataka Active Unlisted Active Compliant
Share
Connect MCP
BR Bal Research Foundation
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Bal Research Foundation — 360° Intelligence Report

Generated from MCA filings & public records
68/100
Trust Score
Moderate

Bal Research Foundation is assessed as Moderate with a Trust Score of 68/100. Bal Research Foundation is an active private not for profit company incorporated in 2014, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 25 Jul 2026 from the latest processed filings. Bal Research Foundation snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
68/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
10/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 93/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
RAVINDRAKUMAR KOTHARI 01234567 Director 01/04/2018 6 yrs Approved
SHAILESH DHEERAJMAL SIROYA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Bal Pharma Limited
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Bal Pharma Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 70
Growth signals & trust indicators
Operating for 11+ years.
Distress signals & risk flags
Negative net worth.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence79/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment46/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view40/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
20 Oct 2023
Director ceased
GANUGAPATI SREERAMA SUBBARAO
29 Sep 2023
Director ceased
RAVINDRAKUMAR KOTHARI
18 Jul 2023
Director appointed
RAVINDRAKUMAR KOTHARI (Director)
30 Sep 2021
Director ceased
DATTATRAYA LAXMINARAYANA BHAT
04 May 2021
Director ceased
SUBBARAO PRASANNA
31 Mar 2016
Share transfer (FY 2016)
20000.00000000 shares to Siroya Shailesh
30 Sep 2015
Director ceased
SHAILESH DHEERAJMAL SIROYA
Director ceased
IVATURI RAMAKRISHNA
22 Dec 2014
Director appointed
SHAILESH DHEERAJMAL SIROYA (Director)
29 Oct 2014
Incorporated
Registered with Roc Bangalore
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Prakruthi Enviro Tech Solutions Private Limited U41000TG2017PTC121022 Miyapur, Hyderabad-500049, Telangana, India
Vignana Jyothi Foundation For Entrepreneurial Excellence U74999TG2017NPL118543 Hyderabad, Telangana, India
Igl India Transplantation Solutions Private Limited U74999TN2020FTC134360 Chennai, Tamil Nadu, India
Clout Bio Innovators Private Limited U74990KL2018PTC054226 Trivandrum, Kerala, India
Niragas Sustainable Ecolife (Opc) Private Limited U74999MH2017OPC296059 Dhule, Maharashtra, India
Bioaxis Dna Research Centre Private Limited U93000TG2008PTC060478 Hyderabad, Telangana, India
Purple Laboratories Private Limited U73200GJ2020PTC116260 Sanand, Gujarat, India
Lynmax Automations Private Limited U29100TN2020PTC139396 Saidapet, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Bal Research Foundation before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Bal Research Foundation: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 50/100, margin trends, ownership structure and peer set for Bal Research Foundation - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Bal Research Foundation pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Bal Research Foundation - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Bal Research Foundation an active company?

Bal Research Foundation has MCA status “Active” with a compliance score of 93/100 (Low Risk).

Is Bal Research Foundation financially healthy?

Bal Research Foundation has a Financial Health Score of 10/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Bal Research Foundation?

Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Bal Research Foundation?

The ultimate holding entity is Bal Pharma Limited. 2 active director(s) are on record.

Does Bal Research Foundation have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Bal Research Foundation up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).

Is it risky to lend to Bal Research Foundation?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.